Biomarker Study in Participants With Migraine

NCT02766517 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

DRUG: Capsaicin

Sponsor

Eli Lilly and Company